ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 290 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9 | -40.0% | 23 | -42.5% | 0.00% | -50.0% |
| Q1 2023 | $15 | 0.0% | 40 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $15 | -100.0% | 40 | -52.9% | 0.01% | -54.5% |
| Q3 2022 | $30,000 | -6.2% | 85 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $32,000 | +18.5% | 85 | 0.0% | 0.01% | +57.1% |
| Q1 2022 | $27,000 | +92.9% | 85 | +112.5% | 0.01% | +75.0% |
| Q4 2021 | $14,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |